Trials / Unknown
UnknownNCT05915923
Effect of Transcranial Magnetic Stimulation on Dynamic Cerebral Autoregulation in Healthy Adults
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Yi Yang · Academic / Other
- Sex
- All
- Age
- 18 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effect of transcranial magnetic stimulation with different stimulation modes ( 1Hz, 10Hz, sham stimulation ) on cerebral autoregulation.
Detailed description
Current studies have shown that repetitive transcranial magnetic stimulation (TMS) can change the excitability of nerve cells, improve intracerebral artery blood supply, and even reduce the degree of neurological impairment in patients with ischemic stroke.Dynamic cerebral autoregulation (dCA), refers to a complex process in which small intracranial arteries contract or relax to maintain relatively stable cerebral blood volume when systemic arterial blood pressure changes, which can predict the prognosis of patients with ischemic stroke. In this study, we hypothesis that TMS provides neuro-protection by means of improving dCA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 1 Hz Repetitive transcranial magnetic stimulation | After enrollment, healthy adults received rTMS once a day (stimulation plan: stimulation of M1 region on the dominant hemisphere at 1Hz) |
| PROCEDURE | 10 Hz Repetitive transcranial magnetic stimulation | After enrollment, healthy adults received rTMS once a day (stimulation plan: stimulation of M1 region on the dominant hemisphere at 10Hz) |
| PROCEDURE | Sham Repetitive transcranial magnetic stimulation | After enrollment, healthy adults received sham-rTMS once a day with the same parameters as the 10 Hz rTMS group, but the coil rotated 90° away from the scalp |
Timeline
- Start date
- 2023-08-02
- Primary completion
- 2024-04-01
- Completion
- 2024-04-20
- First posted
- 2023-06-23
- Last updated
- 2024-02-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05915923. Inclusion in this directory is not an endorsement.